Clinical development accelerator Quotient Sciences and CRO Lindus Health are joining forces to create a streamlined process for clients to advance from first-in-human (FIH) up to pivotal trials. The ...
Quotient Therapeutics emerged from stealth Nov. 21 with $50 million in funding from the life science investment firm Flagship Pioneering. Quotient’s platform hunts for new drug targets by using ...
SALT LAKE CITY--(BUSINESS WIRE)--Quotient Technology Inc. (NYSE: QUOT) (“Quotient” or the “Company”), the leading digital media and promotions technology company, today announced that it has appointed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results